Active Ingredient: Pidotimod
Dosage: 400 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 20 pills
Availability: Out of stock
Adimod (pidotimod) is an immunomodulatory medication. It stimulates the human immune system to different viruses and bacteria. The latest clinical trials have shown this drug obtains an immunomodulatory activity. It is able both to improve the clinical conditions of patients and to enhance and stimulate their immunity cells.
Adimod is out of stock at the moment but you can explore other products for improving general health.
Adimod has an immunostimulatory and immunoregulatory activity on T lymphocytes, it is indicated in problems of secondary and primary immunity with impaired maturation of T lymphocytes, in respiratory system infections.
Dosage and administration
For oral use.
Acute phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, twice a day, two hours before or two hours after meals and for 15 days. Dose in the elderly and children: Take 1 tablet of 400 mg, twice a day, two hours before or two hours after meals and for 15 days. Prophylactic phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, once a day, two hours before or two hours after meals and for 60 days. Elderly and children: Take 1 tablet of 400 mg, once a day, two hours before or two hours after meals and for 60 days.
Adimod should not be used simultaneously with immunosuppressive treatment or in patients with known hypersensitivity to the product.
This drug is generally well tolerated but it may cause diarrhea in rare cases.
There are no data on overdose when administered at doses higher than those recommended. However, the use of the drug at high doses can cause sedation, ataxia, dyspnea, and cyanosis. Treatment: gastric lavage, use activated carbon, supportive measures.
Adimod does not interfere with the use of antibiotics or modify the side effects caused by them. It can interact with those medications that block or stimulate lymphocyte activity, such as thyreostimuline. It can also interfere with those mechanisms that are somehow connected to the IGE. The intake of this drug with food causes a delay in the absorption of the drug and the reduction of its bioavailability to 50%.